|
For example, as noted by Seeking Alpha, the weight losses from these GLP-1s on the market was far lower than the Viking Therapeutics drug candidate.” With exemplary results like that, so far, Viking Therapeutics could have a potential blockbuster hit on its hands with eventual approval from the US FDA. Keep reading for more info... |
|---|
Investors Alley
Act by Feb. 20th, to collect this 22% dividend
Click HERE to get the full story to smarter income investing.
